Director, HEOR & Value Evidence

Telix Pharmaceuticals (AMER)

20h•Hybrid

About The Position

The Director, HEOR & Value Evidence is a highly analytical and strategically minded Health Economics and Outcomes Research (HEOR) leader responsible for shaping and delivering the value narrative across a diverse portfolio of diagnostic and therapeutic assets. This role sits at a critical crossroads between clinical development and commercial success, transforming scientific data into persuasive, payer-relevant evidence that drives access, reimbursement, and long-term market differentiation. As a key member of the over-arching Value & Access organization, the Director will lead the generation, and translation of robust economic and outcomes evidence required to secure and sustain optimal reimbursement. In parallel, this individual will serve as a clinical and technical subject matter expert, partnering closely with Market Access and Payer teams to support high-stakes external engagements with payers, policymakers, and other senior stakeholders. This role offers a unique hybrid of scientific design and strategic field engagement. The role will not only shape the evidence but also stand at the forefront of the conversation, ensuring that payers understand the full clinical and economic impact of our innovations.

Requirements

PhD, PharmD, or MD in Health Economics, Epidemiology, Public Health, or a related field.
5+ years of HEOR experience within the pharmaceutical or biotechnology industry.
Proven track record in supporting both diagnostic and therapeutic products.
Deep understanding of CMS reimbursement pathways and evidence requirements.
Expertise RWE methodology and longitudinal database analysis.
Exceptional presentation skills; ability to explain complex clinical and economic data to diverse audiences, from medical directors to actuarial teams.
Ability to report directly to cross functional leadership and matrix organization to influence brand strategy from an early stage.

Nice To Haves

Commitment to excellence: Take pride in your work and consistently strive for excellence in everything you do
Results-oriented: Driven to achieve goals and objectives, with a strong focus on delivering measurable results
Creativity and innovation: Possess a willingness to think outside the box and come up with unique and creative solutions to challenges
Strong communication skills: Able to communicate effectively with colleagues and stakeholders at all levels, using clear and concise language
Collaboration: Work effectively as part of a team, actively sharing knowledge and expertise to achieve common goals
Resilience: Demonstrate the ability to bounce back from setbacks and persevere in the face of challenges
Inclusive mindset: Demonstrate an understanding and appreciation for diversity, and actively work to create an inclusive environment where everyone feels valued and respected
Adaptability: Comfortable working in a dynamic environment, able to adjust to changing priorities, and willing to take on new challenges
Ethical behavior: Act with integrity and demonstrate a commitment to ethical behavior in all interactions with colleagues and stakeholders
Continuous learning: Show a commitment to ongoing learning and professional development, continually seeking out opportunities to expand your knowledge and skills

Responsibilities

Collaborate with Clinical Development to incorporate HEOR endpoints into Phase II–IV protocols to ensure data supports "Value-Based" narratives.
Lead the design and execution of Real-World Evidence (RWE) studies and patient registries to characterize disease burden, treatment patterns, and long-term outcomes.
Develop studies that demonstrate clinical utility—showing how the test specifically changes patient management and improve outcomes.
Assist in the delivery of Pre-approval Information Exchanges (PIE), and Value Proposition Support, providing the clinical and health-economic backbone for early and product launch discussions with payers and health systems translating complex HEOR data into compelling clinical narratives.
Act as the clinical subject matter expert during payer meetings to address deep-dive technical questions regarding study design, clinical utility, and patient outcomes.
Take a lead role in synthesizing evidence packages for National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs).
Identify evidence gaps early in the product lifecycle and implement mitigation strategies to meet CMS’s "reasonable and necessary" criteria.
Author and oversee the development of Academy of Managed Care Pharmacy (AMCP) dossiers, and specialized HEOR reports.
Oversee the creation of Budget Impact Models (BIM) and Cost-Effectiveness Analyses (CEA) tailored for both therapeutic interventions and diagnostic workflows.